Source-grounded facts extracted from Guardian Pharmacy Services, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Will Mudd was appointed as Senior Vice President and Chief Financial Officer at Guardian Pharmacy Services, Inc..
“Will Mudd, who currently serves as Senior Vice President, Finance of the Company, has been appointed Senior Vice President and Chief Financial Officer of the Company, also effective as of July 1, 2026.”
David Morris changed role as Executive Vice President, Chief Operating Officer at Guardian Pharmacy Services, Inc..
“The Company also announced on June 22, 2026, that upon Mr. Forbes’s retirement, and also effective as of July 1, 2026, David Morris will transition from his current role as Executive Vice President and Chief Financial Officer of the Company to the role of Executive Vice President, Chief Operating Officer.”
Kendall Forbes departed as Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc..
“On June 22, 2026, Guardian Pharmacy Services, Inc. (the “Company”) announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026.”
Guardian Pharmacy Services, Inc. amended Eighth Amendment to Third Amended and Restated Loan and Security Agreement with Regions Bank, as administrative agent and collateral agent valued at Amendment to extend maturity date to May 21, 2030 and increase borrowing capacity up to $80 million (effective 2026-05-21).
“On May 21, 2026, Guardian Pharmacy Services, Inc. (the “Company”), as borrower, and certain of its subsidiaries, as guarantors, entered into the Eighth Amendment (the “Amendment”) to the Third Amended and Restated Loan and Security Agreement dated as of April 23, 2018 (as amended from time to time, the “Loan Agreement”), with the lenders party thereto and Regions Bank, as administrative agent and collateral agent.”
Guardian Pharmacy Services, Inc. amended revolving credit with Regions Bank maturing May 21, 2030.
“extend the maturity date of the revolving loan commitments from April 23, 2027 to May 21, 2030”
Guardian Pharmacy Services, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-05 meeting.
“The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.”
Guardian Pharmacy Services, Inc. shareholders approved Approval, on a Non-Binding Advisory Basis, of the Frequency of the Company’s Future Advisory Votes to Approve the Compensation of the Company’s Named Executive Officers at the 2026-05-05 meeting.
“The stockholders of the Company approved, on a non-binding advisory basis, a one-year frequency for the Company’s future advisory votes to approve the compensation of the Company’s named executive officers.”
Guardian Pharmacy Services, Inc. shareholders approved Approval, on a Non-Binding Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-05-05 meeting.
“The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as described in the proxy statement for the Annual Meeting.”
Guardian Pharmacy Services, Inc. shareholders approved Election of Class II Directors at the 2026-05-05 meeting.
“The stockholders of the Company elected to the Company’s Board of Directors each of the Class II director nominees named below, to hold office until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors are duly elected and qualified.”
Guardian Pharmacy Services, Inc. reported the quarter ended March 31, 2026 results: revenue $336.6 million, net income $13.5 million, EPS $0.21. Guidance raised.
“announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results • Revenue of $336.6 million, up 2% year-over-year. • Residents served ended the quarter at approximately 207,000, up 10% year-over-year. • Net Income of $13.5 million, compared to $9.3 million in the”
Guardian Pharmacy Services, Inc. entered into Stock Purchase Agreement with certain holders valued at up to an aggregate of 1,833,344 shares of Class A common stock (effective 2026-03-18).
“On March 18, 2026, Guardian Pharmacy Services, Inc. (the “Company”) entered into stock purchase agreements (each, a “Stock Purchase Agreement” and collectively, the “Stock Purchase Agreements”) with certain holders (the “Holders”) of shares of the Company’s Class A common stock that were issued upon conversion of shares of the Company’s Class B common stock originally issued in connection with the Company’s corporate reorganization in September 2024.”
Guardian Pharmacy Services, Inc. reported full year 2026 results: revenue $1.40 billion – $1.42 billion. Guidance raised.
“FY 2026 Outlook – Raising Adjusted EBITDA Guidance The guidance below excludes future acquisitions. Updated Guidance Previous Guidance Revenue $1.40 billion – $1.42 billion $1.40 billion – $1.42 billion Adjusted EBITDA $120 million – $124 million $115 million – $118 million”
Guardian Pharmacy Services, Inc. reported full year ended December 31, 2025 results: revenue $1.45 billion, net income $49.0 million, EPS $0.78.
“Revenue of $1.45 billion, up 18% from $1.23 billion in the prior year period with organic growth of 13%. • Net Income (loss) of $49.0 million, compared to ($71.0) million in 2024. • Adjusted EBITDA of $115.1 million, up 27% compared to $90.8 million year over year. • Diluted EPS of $0.78, with Adjusted EPS of $1.07 1 . • Cash and cash equivalents totaled $65.6 million at year end, up from $4.7 million at the end of 2024.”
Guardian Pharmacy Services, Inc. reported fourth quarter ended December 31, 2025 results: revenue $397.6 million, net income $21.3 million, EPS $0.33.
“Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. • Residents served ended the quarter at approximately 205,000, up 10% year-over-year. • Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. • Adjusted EBITDA of $39.5 million, up 53% year over year. • Diluted EPS of $0.33 for the quarter, with Adjusted EPS of $0.37.”
Thomas Salentine, Jr. was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
Mary Sue Patchett was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
Randall Lewis was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
Steve Cosler was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
John Ackerman was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
William Bindley was elected as Director at Guardian Pharmacy Services, Inc..
“On September 25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.